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Cell cultures from neuronal and glial origin have proven to be powerful tools for elucidating cellular and
molecular mechanisms of nervous system development and physiology, and as neurotoxicity models to
evaluate in vitro the possible effects of chemicals. But cellular heterogeneity of nervous system is
considerable and these cells have been shown to respond diversely to neurotoxic insults, leading to
disparate results from different studies. To shed more light on suitability of cellular models of nervous
origin for neurotoxicity screening, the objective of this study was to compare the sensitivity to genetic
damage induction of two nervous cell lines. To this aim, neurons (SH-SY5Y) and glial (A172) cells were
treated with differently-acting genotoxic agents (bleomycin, actinomycin-D, methyl methanesulfonate,
mitomycin C, and griseofulvin). After discarding cytotoxicity, genotoxicity was evaluated by a battery of
assays encompassing detection of different genetic lesions. Results obtained showed that glial cells are
generally more resistant to genotoxic damage induced by clastogenic agents, but more sensitive to
aneugenic effects. These results highlight the need of proper design of in vitro neurotoxicology studies,
especially for neurogenotoxicity screening, emphasizing the importance of employing more than one
nervous cell type for testing the potential toxicity of a particular exposure.
© 2017 Published by Elsevier Ltd.1. Introduction
In the last decades, several in vitro methods have been stan-
dardized and validated to replace or reduce some in vivo tests, since
animal studies are expensive, require a considerable number of
individuals and raise important ethical concerns (Carﬁ et al., 2007).
However, in vitro neurotoxicity screening is not such advanced yet
mainly due to the immense complexity and cellular heterogeneity
of nervous system. Moreover, in vitro test systems currently avail-
able cannot be used to assess neurobiological functions such as
cognition, motor coordination, sensory processing or integration
(Coecke et al., 2006). Still, a number of biological processes that are
general functional targets for neurotoxicants in vivo can be studied
using in vitro systems, including morphological changes such as
size and shape of cell body, neurite outgrowth, myelin formation, or
metabolic and genomic alterations (Bal-Price et al., 2010; Tiffany-Research Services Building,
ias).Castiglioni, 2004). Hence, in vitro studies provide an understand-
ing of the molecular/cellular mechanisms potentially involved in
neurotoxicity, and, consequently, are ordinarily accepted and
considered complementary to animal tests.
There are several in vitro models commonly used to test
neurotoxicity (stem cells, primary cultures, brain slices…) but cell
lines have a number of advantages that make them very suitable to
carry out neurotoxicological studies (reviewed in Banker and
Goslin, 1998). Neuronal systems include diverse cell types among
which perhaps not only one but several may be ideal for a particular
experiment. In order to obtain valuable results, the speciﬁc culture
system to be employed in neurotoxicity screeningmust be carefully
selected on the basis of the cellular problem to be addressed and
the own biological and developmental features of the candidate
cells (reviewed in Hollenbeck and Bamburg, 2003). A172 glioblas-
toma cell line and SH-SY5Y neuroblastoma cell line are salient ex-
amples of such cell lines of human origin that have been routinely
used in in vitro studies to elucidate basic neurobiological principles
and mechanism of chemical action.
A172 is an astrocytoma non-tumorigenic cell line derived from a
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neurotoxicity as a glial model (Choi et al., 2004; Davis et al., 2002;
de Ridder et al., 1987; Stark et al., 1992). SH-SY5Y is a neuroblas-
toma cell line extensively used as an in vitro neuronal model for the
exploration of toxic cellular mechanisms and neurotoxin screening
(Coleman et al., 2002). These neuronal cells present the capability
of proliferating in culture for long periods without contamination, a
prerequisite for the development of an in vitro cell model, and
possess many biochemical and functional features of neurons even
though, due to their immature neoplastic neural crest origin, they
preserve properties of stem cells (Xie et al., 2010). These two cell
lines model the basic cell types of the human central nervous
system, astrocytes and neurons. However, due to their different
properties and functions in the nervous systeme neuronal cells are
in close contact with astroglial cells (neuroglia, which make up
about half the brain), which are considered as supporting cells for
neurons (Allen et al., 2013) e, they are expected to respond
differently against external insults.
On this basis, the main objective of the present study was to
compare the different sensitivity to genetic damage induction of
two cellular models commonly employed for in vitro neurotoxicity
screening. To achieve this aim, neurons (SH-SY5Y) and glial (A172
astrocytes) cells were treated with a set of well-known differently
acting genotoxic agents (i.e. bleomycin [BLM], actinomycin-D [Act-
D], methyl methanesulfonate [MMS], mitomycin C [MMC], and
griseofulvin [GF]). After discarding cytotoxicity by means of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)
assay, genotoxicity induced by these compounds was evaluated in
neuronal and glial cells by a battery of assays encompassing
detection of a range of genetic lesions, namely comet assay, gH2AX
analysis, and micronucleus (MN) test.
2. Materials and methods
2.1. Chemicals
BLM (CAS No. 11056-06-7), Act-D (CAS No. 50-76-0), MMS (CAS
No. 66-27-3), MMC (CAS No. 50-07-7), GF (CAS No. 126-07-8), MTT
(CAS No. 298-93-1), RNase A, and propidium iodide (PI) were
purchased from Sigma-Aldrich Co. BLM, MMS, MMC, and Act-D
were dissolved in sterile distilled water (dH2O), and GF was dis-
solved in dimethyl sulfoxide (DMSO) (CAS No. 67-68-5) from
Sigma-Aldrich Co.
2.2. Cell culture
Human neuroblastoma SH-SY5Y and human glioblastoma
A172 cell lines were obtained from the European Collection of Cell
Cultures. SH-SY5Y cells were cultured in nutrient mixture EMEM/
F12 (1:1) medium with 1% non-essential aminoacids, 1% antibiotic
and antimycotic solution, and supplemented with 10% heat-
inactivated foetal bovine serum (FBS). Culture medium of
A172 cell line consisted of DMEM (high glucose) with 2 mM L-
glutamine, 1% antibiotic and antimycotic solution, and 10% FBS.
Cells were incubated in a humidiﬁed atmosphere with 5% CO2 at
37 C. To carry out the experiments, between 5  104 and
8 104 cells, depending on the approach employed, were seeded in
96-well plates (ﬂat bottom) and allowed to adhere for 24 h at 37 C.
2.3. Treatments
To carry out the treatments, cells were exposed for 3 h at 37 C
with the speciﬁc genotoxic agent at four different concentrations
(1% of ﬁnal volume). The negative control used for BLM, MMS,
MMC, and Act-D experiments was dH2O, whereas DMSO wasemployed as negative control for GF experiments. The chemicals
used, their respective concentrations, as well as the treatment time,
were selected on the basis of previous studies (Garriott et al., 2002;
Luukkonen et al., 2011; Wolff et al., 1999). Triton X-100 (1%) was
used as positive control for viability assays.
2.4. Cellular viability
MTT assay was performed according to Mosmann (1983) in or-
der to evaluate the effects of the different compounds on SH-SY5Y
and A172 cell viability and choose the concentrations for the gen-
otoxicity tests. A total of 11 concentrations were employed in each
case: BLM (0.1e100 mg/ml; i.e. 0.07e70 mM), Act-D (0.01e100 mg/
ml; i.e. 0.01e80 mM), MMS (1e300 mg/ml; i.e. 0.01e2.7 mM), MMC
(0.05e100 mg/ml; i.e. 0.1e300 mM), and GF (0.5e300 mg/ml; i.e.
1.5e850 mM). Brieﬂy, after exposure, treatment solutions were
removed, cells were washed with PBS twice, 100 ml of MTT dye
(500 mg/ml) dissolved in serum free medium were added to each
well, and the plate was incubated at 37 C for 4 h (protected from
light). At the end of this period, MTT solution was removed and
200 ml of DMSO were added. For complete dissolution of purple
formazan crystals, content of each well was quickly resuspended
and the plate was kept away from light for an additional period of
5e10 min. Absorbance was measured at 570 nm using a SPEC-
TROSTAR Nano microplate reader (BMG Labtech).
2.5. Comet assay
After treatments with the different compounds, the alkaline
comet assay was performed following the general protocol pro-
posed by Singh et al. (1988), with minor changes. Brieﬂy, after
collecting cells by trypsinization at 0.05%, they were suspended in
80 ml of low-melting-point agarose (LMA) at 0.7% in PBS (pH 7.4)
Cells were then dropped onto a slide (two drops/slide) previously
pre-coated with 1% normal-melting-point agarose in PBS, covered
with coverslips and placed on ice for 10 min to allow agarose so-
lidiﬁcation. Coverslips were then removed and slides were carefully
immersed in lysing solution (2.5 M NaCl, 100 mM Na2EDTA, 10 mM
TriseHCl, pH 10, with 1% Triton X-100 added just before use) and
left overnight at 4 C in the dark. All steps after lysis were con-
ducted under dim light to prevent the occurrence of additional DNA
damage. Slides were placed in a horizontal gel electrophoresis tank
with alkaline solution (1 mM Na2EDTA, 300 mM NaOH, pH > 13)
into an ice bath, and they were left for 40 min to allow DNA un-
winding and alkali-labile site expression. Electrophoresis was car-
ried out for 30 min at 25 V and 300 mA (0.71 V/cm). After
electrophoresis, slides were rinsed three times for 5 min each with
neutralising solution (0.4 M TriseHCl, pH 7.5), left to air-dry in the
dark, and stained with 40 ml of 5 mg/ml 4,6-diamidino-2-
phenylindole (DAPI) in antifade solution, and covered with a
coverslip. The preparations were kept in a humidiﬁed sealed box to
prevent drying of the gel and analysed within 48 h to avoid
excessive diffusion of the DNA in the gel. Image capture and anal-
ysis were performed using the Comet IV Software (Perceptive In-
struments). In all cases 50 cells were scored from each replica (i.e.
100 cells in total), and percentage of DNA in the comet tail (%tDNA)
was used as DNA damage parameter.
2.6. gH2AX analysis
gH2AX analysis was conducted following the protocol described
by Tanaka et al. (2009), with somemodiﬁcations (Valdiglesias et al.,
2011). The ﬂow cytometry analysis was performed in a FACSCalibur
ﬂow cytometer (Becton Dickinson). Cell populations were gated
according to size (forward scattering) and complexity (side
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acquired, obtaining data from FL1 (gH2AX-Alexa Fluor 488) and FL2
(propidium iodide, PI) detectors. Data were analysed using Cell
Quest Pro software (Becton Dickinson); the percentage of gated
cells positive for both gH2AX and PI were calculated with regard to
the total cells gated.
2.7. Micronucleus evaluation by ﬂow cytometry
After 3 h treatments in the presence of BLM, Act-D, MMS, MMC
or GF, cells were cultured in fresh medium for an additional period
of 24 h (SH-SY5Ycells) or 48 h (A172 cells), adjusted according to
each cell cycle duration. Subsequently, a suspension of nuclei and
MNwas prepared as previously described (Valdiglesias et al., 2011).
The ﬁnal suspension was analysed with a FACSCalibur ﬂow cy-
tometer (Becton Dickinson) employing Cell Quest Pro software
(Becton Dickinson) for data analysis. For each sample, at a mini-
mum, 50,000 events were evaluated from the PI signal detected in
the FL2 channel. The percentage of MN was calculated with regard
to the total number of nucleus and MN gated.
2.8. Statistical analysis
A minimum of three independent experiments were performed
for each experimental condition tested, and each experiment was
performed in duplicate. Experimental data were expressed as
mean ± standard error. Differences among groups were tested with
KruskaleWallis test and ManneWhitney U test, whereas Spear-
man's correlation was employed to analyse the possible associa-
tions between two variables. A p value < 0.05 was considered
signiﬁcant. Statistical analyses were performed using SPSS for
Windows statistical package (version 20.0).
3. Results
Prior to genotoxicity evaluation, MTT was carried out in
neuronal and glial cells to check viability after exposure to a wide
range of concentrations of BLM, Act-D, MMS,MMC and GF. BLMwas
found to induce dose-response decreases in viability of both cell
types (A172: r ¼ 0.712 p < 0.01; SH-SY5Y: r ¼ 0.754, p < 0.01),
although neurons resulted more sensitive than glial cells with
statistically signiﬁcant differences in viability from 2.5 to 10 mg/ml
on, respectively (Fig. 1a). Similarly, treatment with MMS induced a
dose-dependent decrease in viability of both A172 (r ¼ 0.836,
p < 0.01) and SH-SY5Y (r ¼ 0.935, p < 0.01) cells; these last ones
were much more sensitive to MMS effects, with no living cells
beyond 100 mg/ml (Fig. 1c). Act-D and MMC presented similar re-
sponses in the tested cells with slight effects on glial cells but
relevant dose-dependent decreases in neuron viability after both
Act-D (r ¼ 0.710, p < 0.01) (Fig. 1b) and MMC (r ¼ 0.748, p < 0.01)
(Fig. 1d) treatments. Opposite to the other compounds, GF induced
more accused cytotoxicity in glial cells (r ¼ 0.773, p < 0.01) as
compared to neuron cells (r ¼ 0.471, p < 0.01) (Fig. 1e). From the
results obtained in all these experiments, four different concen-
trations were selected in each case to perform the subsequent
genotoxicity testing, i.e. 0.25, 1, 10 and 50 mg/ml (0.2, 0.7, 7 and
35 mM) for BLM; 0.01, 0.25, 5 and 25 mg/ml (0.01, 0.2, 4 and 20 mM)
for Act-D; 1, 2.5, 10 and 50 mg/ml (9, 23, 91 and 450 mM) for MMS;
0.2, 1.75, 8.5 and 35 mg/ml (0.6, 5, 24 and 100 mM) for MMC, and 5,
15, 50 and 100 mg/ml (14, 43, 142 and 284 mM) for GF.
In order to evaluate the differences in responding to DNA
damage induction, three different genotoxicity approaches, namely
comet assay, gH2AX analysis and MN test, were carried out in
neuronal and glial cells after being treated for 3 h with the different
agents. Results obtained from these experiments are shown inFigs. 2e6.
Increased values of primary DNA damage (A172: r ¼ 0.716,
p < 0.01; SH-SY5Y: r ¼ 0.866, p < 0.01) (Fig. 2a) and gH2AX (A172:
r ¼ 0.496, p < 0.01; SH-SY5Y: r ¼ 0.741, p < 0.01) (Fig. 2b) were
observed in both cell types at all concentrations tested. Moreover,
despite no MN production was observed in glial cells treated with
BLM, this compound did induce increases in MN frequency in SH-
SY5Y cells (r ¼ 0.542, p < 0.01), signiﬁcant from 1 mg/ml concen-
tration on (Fig. 2c.
Act-D caused similar concentration-dependent primary DNA
damage in both cell types (A172: r ¼ 0.874, p < 0.01; SH-SY5Y:
r ¼ 0.822, p < 0.01) (Fig. 3a). However, minor effects were
observed in phosphorylation of H2AX in glial cells treated with Act-
D while important levels of gH2AX were found in SH-SY5Y cells
(r ¼ 0.520, p < 0.01), particularly high at 0.25 and 5 mg/ml con-
centrations (Fig. 3b). Similarly, A172 cells showed slight increases in
MN frequency just at 0.01 and 25 mg/ml. On the contrary, a marked
dose-dependent MN formation was observed in neuronal SH-SY5Y
cells after treatments (r ¼ 0.877, p < 0.01) (Fig. 3c).
Important increases in primary DNA damage were found in
A172 (r ¼ 0.945, p < 0.01) and SH-SY5Y (r ¼ 0.896, p < 0.01) cells
(Fig. 4a). However, neither H2AX phosphorylation nor MN induc-
tion were observed in both cell types after MMS treatments,
excepting a slight increase in neuronal cells treated with the
highest concentration (Fig. 4b and c).
Treatments withMMC caused increases in primary DNA damage
(Fig. 5a) and MN frequencies (Fig. 5c) in both cell lines tested, with
positive dose-response relationships (%tDNA: r ¼ 0.885, p < 0.01 in
A172, and r ¼ 0.882, p < 0.01 in SH-SY5Y; %MN: r ¼ 0.645, p < 0.01
in A172, and r ¼ 0.757, p < 0.01 in SH-SY5Y). Nevertheless, only
neuronal cells showed relevantly increased levels of phosphory-
lated H2AX (Fig. 5b).
In the case of GF, treatments with this compound induced pri-
mary DNA damage in A172 cells at the highest concentration and in
SH-SY5Y from 15 mg/ml on (Fig. 6a), phosphorylation of H2AX in
both cell types only at 100 mg/ml, (Fig. 6b), and MN formation
related to dose (r ¼ 0.645, p < 0.01) in A172 cells (Fig. 6c).
4. Discussion
In vitro models are useful for the rapid screening of large
numbers of agents regarding their potential to produce toxicity.
Although cell cultures fromneuronal origin are in someway limited
since they do not reﬂect the complex physiology of the nervous
system, they have proven to be powerful tools for elucidating
cellular and molecular mechanisms of nervous system develop-
ment and function, often predicting those observed in vivo
(Ramabhadran et al., 2010). Cell cultures derived from nervous
system are also frequently used to understand the mechanism of
action of neurotoxic agents and to assess critical cellular events of
neurodevelopment, including neural differentiation and neurite
growth (Bal-Price et al., 2010). Thus, different cells of neural origin,
including neurons, astrocytes, oligodendrocytes or microglial cells
are commonly used as neurotoxicity models to evaluate in vitro the
possible effects of chemicals and drugs to the cells and physiology
of the nervous system. However, since they have different purpose
in the organism, they are expected to respond to neurotoxic insults
in a disparate way, making it difﬁcult to establish the neurotoxic
risk of one speciﬁc agent. Indeed, the diverse response of these cells
against the same external insult (Coccini et al., 2015; Coleman et al.,
2002), and also the different effects manifested regarding cells from
other origins (e.g., hepatocytes, kidney cells, lymphocytes, skeletal
muscle cells, etc.) (Rovetta et al., 2007; Valdiglesias et al., 2010)
have been previously documented, supporting the relevance of
employing particularly nervous system cell types for testing the
Fig. 1. Viability of glial and neuronal cells treated with BLM (a), Act-D (b), MMS (c),
MMC (d) and GF (e), evaluated by MTT assay. Representative results from three in-
dependent experiments. **P < 0.01; *P < 0.05, signiﬁcant difference with regard to the
negative control. PC: positive control.
Fig. 2. Genotoxicity in glial and neuronal cells treated with BLM. Comet assay (a),
gH2AX analysis (b), and MN frequency determined by ﬂow cytometry (c). Represen-
tative results from three independent experiments. **P < 0.01, signiﬁcant difference
with regard to the corresponding control.
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brain barrier (e.g., nanomaterials). Moreover, most studies found
in the literature employed just one of these cell types, restrictingthe neurotoxicity assessment perspective.
In the present study, two cell lines from human nervous system,
gliomal A172 and neuroblastomal SH-SY5Y cells, were utilized in
order to evaluate the different response of these cells to genetic
damage induction. Considering that a distinction on whether a
toxic agent affects neurons or glial cells is necessary in neurotox-
icity screening, these cell lines were selected since both of them
have been extensively used as neurotoxicity models and because
they are from human origin, avoiding the need for interspecies
extrapolation of results, which is not always straightforward.
MTT cytotoxicity assay was applied as an initial “screening” to
compare the primary response of the different cells to the chal-
lenging agent, and to deﬁne the non-cytotoxic concentrations that
would be later tested using genotoxicity speciﬁc endpoints. Results
from these viability experiments showed that neurons are more
sensitive to cytotoxic effects of agents tested in all cases excepting
for GF, which induces similar cytotoxicity in both cell types. This
Fig. 3. Genotoxicity in glial and neuronal cells treated with Act-D. Comet assay (a),
gH2AX analysis (b), and MN frequency determined by ﬂow cytometry (c). Represen-
tative results from three independent experiments. *P < 0.05, **P < 0.01, signiﬁcant
difference with regard to the corresponding control.
Fig. 4. Genotoxicity in glial and neuronal cells treated with MMS. Comet assay (a),
gH2AX analysis (b), and MN frequency determined by ﬂow cytometry (c). Represen-
tative results from three independent experiments. **P < 0.01, signiﬁcant difference
with regard to the corresponding control.
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neuronal cells to cytotoxicity induction as compared to glial cells
(Coccini et al., 2015; Coleman et al., 2002; Rovetta et al., 2007). The
relatively higher resistance of A172 cells to toxicity compared with
the SH-SY5Y cells reﬂects to some extent the role of astrocytes
in vivo. Astroglial cells are known to protect neuronal cells against
stress conditions in vivo and in vitro (Saeed et al., 2015). On the basis
of the results of MTT experiments, four concentrations were chosen
in each case to perform the genotoxicity analysis, always consid-
ering a viability higher than 60% to avoid interference of cytotox-
icity with the genotoxicity evaluation. Just one exceptionwas made
in the case of the highest concentration chosen for BLM (50 mg/ml),
which was selected despite the low viability of SH-SY5Y cells (41%)
in order to make a proper comparison with A172 cells.
BLM is a well-known clastogenic agent, capable of inducing a
wide spectrum of mutagenic lesions in mammalian cells, including
DNA base damage, abasic sites, and alkali-labile sites (Chen and
Stubbe, 2004; Milic and Kopjar, 2004; Povirk and Austin, 1991),which eventually result in DNA single (SSBs) and double (DSBs)
strand breaks. Consequently, it has been extensively used as DNA
damage inductor and positive control in genotoxicity assays (Laffon
et al., 2010; Mira et al., 2013; Valdiglesias et al., 2013a). From the
MTTexperiments, high sensitivity to BLMwas observed in both SH-
SY5Y and A172 cells, especially pronounced in neurons, which
resulted substantially affected from 0.5 mg/ml on. H2AX phos-
phorylation to generate gH2AX is an early indicator of DSB pro-
duction, since this process is a signal for the recruitment of the
different elements participating in DSB repair (Valdiglesias et al.,
2013b). As for alkaline comet assay, it detects primary damage in
the DNA e including SSBs, DSBs, alkali-labile sites and incomplete
excision repair sites (Collins et al., 2014) e, and MN contain chro-
mosome breaks or whole chromosomes lagged behind during
anaphase, hence MN test reveals both clastogenic and aneugenic
events (Fenech, 2008). As it was expectable due to its ability to
generate DSBs and SSBs, signiﬁcant dose-dependent increases in
Fig. 5. Genotoxicity in glial and neuronal cells treated with MMC. Comet assay (a),
gH2AX analysis (b), and MN frequency determined by ﬂow cytometry (c). Represen-
tative results from three independent experiments. **P < 0.01, signiﬁcant difference
with regard to the corresponding control.
Fig. 6. Genotoxicity in glial and neuronal cells treated with GF. Comet assay (a), gH2AX
analysis (b), and MN frequency determined by ﬂow cytometry (c). Representative re-
sults from three independent experiments. *P < 0.05, **P < 0.01, signiﬁcant difference
with regard to the corresponding control.
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observed in both cell lines at all concentrations tested. However,
although a dose-dependent increase in MN frequency was also
obtained in neuronal cells, no induction of MN was found in as-
trocytes, indicating that these cells are able to repair the strand
breaks initially induced by BLM and supporting the more marked
sensitivity of neurons, which did ﬁx that damage as chromosome
alterations. Neurotoxic potential of BLM on neuronal and glial cells
has been previously reported (Araki et al., 1998; Hosoi et al., 1998).
Also, current results agreed with other previous experiments car-
ried out in our laboratory, inwhich BLM (1 mg/ml) was employed as
positive control for gH2AX analysis and comet assay in SH-SY5Y,
inducing statistically signiﬁcant notable increases in %gH2AX and
%tDNA, respectively (Kiliç et al., 2016; Valdiglesias et al., 2010).
Besides, this positive response was obtained regardless treatment
time (3 or 24 h) or culture medium conditions (with or without
serum supplementation). In gH2AX experiments with A172 cells,BLM was also found to induce relevant increases in DSB formation
(unpublished results).
Act-D is an intercalating agent; it intercalates into DNA strands
leading to DNA damage and inhibition of mRNA synthesis by
interfering with RNA polymerase (Bensaude et al., 1999; Trask and
Muller, 1988) and inducing both SSBs and DSBs (Mischo et al.,
2005). In our study, no cytotoxic effects in A172 cells treated with
this chemical were observed. Oppositely, low Act-D doses (0.5 mg/
ml) induced 30% decrease in SH-SY5Y viability. Regarding geno-
toxicity, a signiﬁcant dose-dependent increase in gH2AX levels and
primary DNA damage was found in both cell lines. Phosphorylation
of H2AX was especially noticeable in neuronal cells (20-fold in-
crease at 5 mg/ml). However, similarly to the response to BLM, the
great majority of Act-D-induced damage was repaired by the glial
cells avoiding MN formation, while in neurons it resulted in a dose-
dependent increase of chromosome alterations. Supporting our
results, Act-D has been found to induce DNA damage in a number of
studies employing other different cell lines and it is also commonly
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(Hashimoto et al., 2010; Porcedda et al., 2006; Sanchez-Flores et al.,
2015). In a previous studywith primary rat neurons, it was reported
that cells remained alive and intact after 48 h of 0.1 mg/ml Act-D
treatment (Martin et al., 1988). The authors explained these re-
sults in light of the fact that neurons could survive after 4e5 d of
complete protein synthesis inhibition. Apart from this pioneer
study, the information regarding neurotoxic effects of this com-
pound is very scarce.
MMS is an alkylating compound which methylates DNA bases,
usually guanine producing O6-methylguanine adducts, in a random
manner (Ma et al., 2011). This causes SSBs that may lead to DSBs
through either replication or repair processes (Zhou et al., 2006).
Accordingly, MMS is another chemical usually employed as positive
control in genotoxicity assays. Very high cytotoxic concentration-
dependent damage was observed in both cells lines after MMS
treatment, although it was especially extreme in the case of
neuronal cells, with no surviving cells beyond 100 mg/ml. However,
despite these marked effects on viability, genetic damage induced
in both SH-SY5Y and A172 cells resulted limited, with no effects
observed in gH2AX levels or MN frequency, and just dose-
dependent increases in %tDNA. According to the negative gH2AX
and MN results, MMS clastogenic effect observed in comet assay is
not related to DSB production and is repaired before cell division.
Only a slight MN increase was obtained at the highest concentra-
tion in SHSY5Y cells, but it was probably due to the high cytotox-
icity induced at this dose and therefore to the presence of apoptotic
cells rather than chromosome fragmentation itself. In contrast to
our results, Koyama et al. (2008) evaluated MMS effects on
A172 cells and observed no decreases in viability after treatments
with this compound up to 10 h, but formation of apurinic/apyr-
imidinic sites after 2 and 4 h; although concentration employed in
their experiments was 1 mM (0.11 mg/ml), one order of magnitude
below the lowest dose employed in the current study. In agreement
with our ﬁndings, Sakuma et al. (2006) reported a time- and dose-
dependent increase of DNA strand breaks (evaluated by comet
assay) in A172 cells treated with MMS (2e20 mg/ml). In neurons,
Luukkonen et al. (2011) reported statistically signiﬁcant decrease in
viability and increase in primary DNA damage (comet assay) and
MN frequency in SH-SY5Y cells after exposure to MMS (15e35 mg/
ml). And Kulkarni et al. (2008) reported viability results similar to
those observed in the present study in differentiated SH-SY5Y cells
treated with higher MMS doses (500-1500 mM, equivalent to
55e165 mg/ml) for 1 h.
MMC is a potent antineoplastic drug that has been employed in
chemotherapy of a number of cancers, including breast, lung,
prostate, colorectal, and bladder cancer (Milic and Kopjar, 2004). It
is also a well-known cross-linking substance extensively used as
clastogenic agent and MN inducer in many in vitro and in vivo
studies (Kataria et al., 2016; Nesti et al., 2000; Valdiglesias et al.,
2011). No decrease in viability of glial cells was observed at any
concentration tested, and signiﬁcant decreases in neuronal viability
were found only from 20 mg/ml on. Still, genetic damage was more
noticeable, with positive responses in comet assay in both cell lines,
and in H2AX phosphorylation in neuronal cells. Also MN fre-
quencies resulted signiﬁcantly higher after MMC treatments in
both lines at all concentrations tested, suggesting that this com-
pound causes DSBs eventually leading to chromosome alterations,
but by different ways in neurons and in astrocytes according to the
different results obtained under the same experimental conditions.
In the case of glial cells, no marked positive response in gH2AX
analysis (no relevant DSB induction), but clearly positive comet
assay results (SSB and/or DSB production), suggest that MMC
induced DSBs mainly indirectly, by causing SSBs which are trans-
formed in DSBs after cell cycle progression, and then become MN.Meanwhile in neuronal cells, MMC induced directly DSBs (both
comet assay and gH2AX analysis positive) which were not able to
be repaired and remained ﬁxed as MN. Agreeing with our results,
MMC (0.08e1.28 mM) was previously found to induce
concentration-dependent decrease in viability and increase in MN
formation in primary cultured astrocytes from new-born male
Sprague-Dawley rats (Miyakoshi et al., 1999). Also, MMC is
frequently used in our laboratory as positive control for MN test. In
previous studies in SH-SY5Y cells, this agent induced signiﬁcant
increases in MN frequency after 3 and 24 h treatments at 1.5 mM
(0.5 mg/ml) dose in both incomplete (serum-free) and complete
culture media (Kiliç et al., 2016; Valdiglesias et al., 2011). Even so
the same concentration was not enough to induce increases in MN
frequency in A172 cells under the same experimental conditions,
and a 10-fold increase MMC concentration (5 mg/ml) was necessary
to obtain a similar positive response in MN test (unpublished
results).
GF is an aneugenic agent that interacts with the cell structure
involved in chromosome segregation, probably by binding to
microtubule-associated proteins and modifying the spindle of the
dividing cell (Nesti et al., 2000; Wehland et al., 1977). Indeed, GF
have been shown to induce aneuploidy in test systems ranging
from in vitro cultured mammalian cells and somatic tissue of intact
animals, to germ cells of rodents (Aardema et al., 1998). Differing
from the results obtained for the other genotoxic agents employed
in the present study, GF resulted less cytotoxic and genotoxic for
neurons than for glial cells, with more accused decrease in viability,
and dose-dependent increases in MN formation just observed in
A172 cells. As aneugenicity caused by GF does not correlate with
gene mutation or clastogenicity induction that results in chromo-
some aberrations via damage to DNA strands (Hashimoto et al.,
2010), the slight positive effects observed in comet and gH2AX
assays are likely due to cytotoxicity. To the best of our knowledge,
there are no reports on GF neurogenotoxicity in the literature.
Nevertheless, another similar aneugenic compound, vincristine,
was observed to induce an important dose-dependent decrease in
viability of glial A172 cells from 1 ng/ml on after a longer treatment
(72 h) (Nakagawa et al., 2007).
5. Conclusions
The main problem in the development of a test strategy with
predictive capacity for neurotoxicity is the complexity of the hu-
man nervous system (Bal-Price et al., 2010). For this main reason,
selection of a particular nervous cellular in vitro system should be
done in a careful way, considering that the different features of the
cell types involved in nervous system physiology may determine
diverse response against toxic insults. Results obtained in the
present study support this need to carry out a correct in vitro
neurotoxicology system selection, but also emphasize the impor-
tance of employing more than one nervous cell type for testing the
potential toxicity of a particular exposure, especially in neuro-
genotoxicity screening, since neurons and astrocytes have been
proved to respond diversely to genotoxicants.
Taking all results obtained from the ﬁve differently acting gen-
otoxic agents together, it seems that glial cells are generally more
resistant to cytotoxic and genotoxic damage induced by clastogenic
agents, showing notable decreases in viability at lower doses of the
challenging compounds and repair of DNA damage usually before it
is ﬁxed as chromosome aberrations; still they are more sensitive to
aneugenic effects. In particular, SH-SY5Y resulted more sensitive
than A172 cells to the effect of DNA binding (BLM) and intercalating
(Act-D) agents; although they produce similar levels of strand
breaks in both cell lines, milder in A172, this DNA damage could be
efﬁciently repaired by glial cells but not by neuronal cells resulting
B. Laffon et al. / Food and Chemical Toxicology 102 (2017) 120e128 127in MN formation in this case. The opposite sensitivity was observed
for aneugenic agents (GF), which only induced chromosome alter-
ations in glial cells. Nevertheless, the response of both cell lines to
the DNA damage induced by alkylating agents (MMS) and cross-
linkers (MMC) was similar, with easily reparable genotoxic effects
(limited to primary DNA damage) in the ﬁrst case, but important
genetic damage (DNA breaks andMN formation) in the second one.
The ﬁve compounds chosen to induce DNA damage, together
with the different genotoxicity outcomes assessed, provide support
to the view that nervous system cells have different sensitivity to
genetic damage induction, as well as offer the basis to properly
employ these approaches as neurotoxicity in vitro models for DNA
damage evaluation.
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